Howard W Robin Nektar Therapeutics (NKTR) insider trading activity

NKTR Quotes by TradingView

Howard W Robin is President & CEO of NEKTAR THERAPEUTICS. Currently has a direct ownership of 1.11 Million shares of NKTR, which is worth approximately $1.03 Million. The most recent transaction as insider was on Dec 18, 2024, when has been sold 85,035 shares (Common Stock) at a price of $0.99 per share, resulting in proceeds of $84,184. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.11M
30.92% 3M change
23.42% 12M change
Total Value Held $1.03 Million

HOWARD W ROBIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2024
SELL
Open market or private sale
$84,184 $0.99 p/Share
85,035 Reduced 7.11%
1,110,675 Common Stock
Dec 17 2024
SELL
Open market or private sale
$47,464 $1.01 p/Share
46,995 Reduced 3.78%
1,195,710 Common Stock
Dec 13 2024
BUY
Grant, award, or other acquisition
-
410,625 Added 24.84%
1,242,705 Common Stock
Nov 19 2024
SELL
Open market or private sale
$16,440 $1.01 p/Share
16,278 Reduced 1.92%
832,080 Common Stock
Aug 19 2024
SELL
Open market or private sale
$19,047 $1.28 p/Share
14,881 Reduced 1.72%
848,358 Common Stock
May 17 2024
SELL
Open market or private sale
$29,137 $1.75 p/Share
16,650 Reduced 1.89%
863,239 Common Stock
Feb 20 2024
SELL
Open market or private sale
$13,622 $0.68 p/Share
20,033 Reduced 2.23%
879,889 Common Stock
Nov 17 2023
SELL
Open market or private sale
$9,739 $0.49 p/Share
19,877 Reduced 2.16%
899,922 Common Stock
Aug 16 2023
SELL
Open market or private sale
$15,598 $0.78 p/Share
19,998 Reduced 2.13%
919,799 Common Stock
May 16 2023
SELL
Open market or private sale
$14,659 $0.72 p/Share
20,361 Reduced 2.12%
939,797 Common Stock
Feb 16 2023
SELL
Open market or private sale
$58,905 $3.0 p/Share
19,635 Reduced 2.0%
960,158 Common Stock
Nov 16 2022
SELL
Open market or private sale
$135,709 $3.57 p/Share
38,014 Reduced 3.73%
979,793 Common Stock
Aug 16 2022
SELL
Open market or private sale
$65,493 $4.76 p/Share
13,759 Reduced 1.33%
1,017,807 Common Stock
Aug 15 2022
BUY
Grant, award, or other acquisition
-
410,625 Added 28.47%
1,031,566 Common Stock
May 16 2022
SELL
Open market or private sale
$144,290 $3.95 p/Share
36,529 Reduced 5.56%
620,941 Common Stock
May 15 2022
BUY
Grant, award, or other acquisition
-
68,450 Added 9.43%
657,470 Common Stock
Feb 16 2022
SELL
Open market or private sale
$136,656 $10.95 p/Share
12,480 Reduced 2.07%
589,020 Common Stock
Dec 16 2021
BUY
Grant, award, or other acquisition
-
126,050 Added 17.33%
601,500 Common Stock
Nov 16 2021
SELL
Open market or private sale
$562,893 $13.16 p/Share
42,773 Reduced 8.25%
475,450 Common Stock
Nov 15 2021
BUY
Grant, award, or other acquisition
-
94,100 Added 15.37%
518,223 Common Stock
Aug 16 2021
SELL
Open market or private sale
$159,252 $13.83 p/Share
11,515 Reduced 2.64%
424,123 Common Stock
May 17 2021
SELL
Open market or private sale
$211,548 $18.3 p/Share
11,560 Reduced 2.58%
435,638 Common Stock
Feb 16 2021
SELL
Open market or private sale
$257,143 $22.37 p/Share
11,495 Reduced 2.51%
447,198 Common Stock
Feb 04 2021
SELL
Open market or private sale
$3,051,000 $20.34 p/Share
150,000 Reduced 24.64%
458,693 Common Stock
Feb 04 2021
BUY
Exercise of conversion of derivative security
$1,320,000 $8.8 p/Share
150,000 Added 19.77%
608,693 Common Stock
HWR

Howard W Robin

President & CEO
San Francisco, CA

Track Institutional and Insider Activities on NKTR

Follow NEKTAR THERAPEUTICS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

News

Receive news related to NEKTAR THERAPEUTICS

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NKTR